| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/24/2003 | WO2002088180A3 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 04/24/2003 | WO2002079432A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/24/2003 | WO2002079429A3 Anti-muc-1 single chain antibodies for tumor targeting |
| 04/24/2003 | WO2002079406A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 04/24/2003 | WO2002079397A3 Virus derived antimicrobial peptides |
| 04/24/2003 | WO2002074959A3 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1 |
| 04/24/2003 | WO2002072822A3 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 04/24/2003 | WO2002072624A3 Assays, methods and means for targeting streptococcal inhibitor of complement (sic) |
| 04/24/2003 | WO2002066507A3 Histidine phosphatase interacting protein of 120 kd |
| 04/24/2003 | WO2002065129A3 Epitopic sequences for diagnosing infection by chlamydia trachomatis |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002064154A3 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 04/24/2003 | WO2002063000A9 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 04/24/2003 | WO2002061039A3 Thuja plicata dirigent protein promotors |
| 04/24/2003 | WO2002060938A3 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof |
| 04/24/2003 | WO2002059298A9 Gab2(p97) gene and methods of use thereof |
| 04/24/2003 | WO2002056900A3 Use of slpi for treating chronic inflammatory intestinal diseases |
| 04/24/2003 | WO2002055717A3 Enhanced secretion of a polypeptide by a microorganism |
| 04/24/2003 | WO2002055707A3 Cloning of an inhibitor of antigen-receptor signaling by a retroviral-based functional screen |
| 04/24/2003 | WO2002055552A3 Soluble cyclic analogues of beta amyloid peptide |
| 04/24/2003 | WO2002050295A3 Arcelin-5 promoter and uses thereof |
| 04/24/2003 | WO2002048367A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/24/2003 | WO2002048174A9 Dimeric fluorescent polypeptides |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002046231A3 Caml-binding peptides |
| 04/24/2003 | WO2002046227A3 Glp-1 fusion proteins |
| 04/24/2003 | WO2002040688A3 Maize yellow stripe1 and related genes |
| 04/24/2003 | WO2002030980A3 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 04/24/2003 | WO2002030975A3 Antifungal peptides |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | WO2002024895A3 Transcription factors and zinc finger proteins |
| 04/24/2003 | WO2002020651A3 Human phermone polypeptide |
| 04/24/2003 | WO2002018651A3 Methods for detecting papillomavirus dna in blood plasma and serum |
| 04/24/2003 | WO2002018585A8 Packaging of positive-strand rna virus replicon particles |
| 04/24/2003 | WO2002012447A3 Isolation and use of solid tumor stem cells |
| 04/24/2003 | WO2002006490A8 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 04/24/2003 | WO2002006342A3 G-protein coupled receptors and nucleic acids encoding same |
| 04/24/2003 | WO2002004513A3 Down syndrome critical region 1-like 1 proteins |
| 04/24/2003 | WO2002000878A3 Human msp1 mitochondrial dynamin, its msp1-x isoforms, and their therapeutic use |
| 04/24/2003 | WO2001078796A3 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 04/24/2003 | WO2001077389A3 Genes expressed in foam cell differentiation |
| 04/24/2003 | WO2001075440A3 Schizophrenia related genes |
| 04/24/2003 | WO2001062791A9 Control of tgf (beta) signaling by km23 superfamily members |
| 04/24/2003 | US20030079254 Enhanced plant cell transformation by addition of host genes involved in T-DNA integration |
| 04/24/2003 | US20030079252 Transgenic plant for use as model in controlling flowering in plants |
| 04/24/2003 | US20030079250 Nucleotide sequences coding polypetide for use in the modification of fatty acids in plants |
| 04/24/2003 | US20030079244 Therapeutic agent for use in the treatment glandular disorders |
| 04/24/2003 | US20030079243 Transgenic mice containing TRP6 calcium ion channel gene disruptions |
| 04/24/2003 | US20030079242 Animal model for use as tool in diagnosing and treating tumors |
| 04/24/2003 | US20030079239 Nucleotide sequences coding polypeptide for use in the treatment of osteoporosis |
| 04/24/2003 | US20030079238 Polynucleotide encoding a human junctional adhesion protein (JAM-2) |
| 04/24/2003 | US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 04/24/2003 | US20030078411 Adeno-associated virus capsid immunologic determinants |
| 04/24/2003 | US20030078410 Expression vector for use in the transfer of genes and preparation of vaccines |
| 04/24/2003 | US20030078409 Nucleotide sequences coding polypeptide for use in the treatment of respiratory system, asthmatic and inflammatory bowel diseases |
| 04/24/2003 | US20030078408 DNA encoding orphan SNORF43 receptor |
| 04/24/2003 | US20030078407 DNA encoding orphan SNORF53 receptor |
| 04/24/2003 | US20030078406 Methods and compositions for DRM, a secreted protein with cell growth inhibiting activity |
| 04/24/2003 | US20030078405 47 human secreted proteins |
| 04/24/2003 | US20030078403 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of psychological disorders |
| 04/24/2003 | US20030078401 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 04/24/2003 | US20030078398 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 04/24/2003 | US20030078396 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 04/24/2003 | US20030078395 Nucleotide sequences coding polypeptide for use in the treatment of hyperlipemia |
| 04/24/2003 | US20030078391 Nucleotide sequences coding polypeptide for use in treatment of periodontal disease |
| 04/24/2003 | US20030078390 Tissue cement proteins from Rhipicephalus appendiculatus |
| 04/24/2003 | US20030078389 Gamma-heregulin |
| 04/24/2003 | US20030078386 Antibody for use in the treatment of viral, gastrointestinal, autoimmune and cell proiferative disorders |
| 04/24/2003 | US20030078383 Novel human LDL receptor family proteins and polynucleotides encoding the same |
| 04/24/2003 | US20030078382 Human Ect2 and methods of use |
| 04/24/2003 | US20030078381 Composition for use in the detection and treatment of cancer |
| 04/24/2003 | US20030078380 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030078379 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030078378 Blocking expression of virulence factors in S. aureus |
| 04/24/2003 | US20030078377 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 04/24/2003 | US20030078375 Nucleotide sequences coding polypeptides for use in the tratment of ischemia-reperfusion injury, restenosis and parasitic diseases |
| 04/24/2003 | US20030078374 Complementary peptide ligands generated from the human genome |
| 04/24/2003 | US20030078373 Chaperone fragments |
| 04/24/2003 | US20030078370 Antibodies to cyclin E2 protein |
| 04/24/2003 | US20030078228 Immunoprotecting transplanted cells using an uncleavable form of FAS protein by introducing into cells a nucleic acid encoding a FAS protein resist to cleavage by an enzyme |
| 04/24/2003 | US20030078223 Administering to individual first dose of composition comprising an immunomodulatory nucleic acid and after suitable time administering second dose of composition comprising an immunomodulatory nucleic acid; antiasthmatics |
| 04/24/2003 | US20030078222 Human receptor tyrosine kinase |
| 04/24/2003 | US20030078221 Method for treating a Complement System-mediated disease comprising administering a pharmaceutically effective amount of a Nucleic Acid Ligand of a Complement System Protein; SELEX method |
| 04/24/2003 | US20030078220 Invention provides genetic variants of the human Interleukin 4 Receptor Alpha (IL4R alpha ) gene and methods for identifying which variants of this gene are possessed by an individual |
| 04/24/2003 | US20030078218 Use of receptor gene designated EX20, the protein molecule encoded by EX20 and related molecules in therapeutic and diagnostic applications |
| 04/24/2003 | US20030078210 Compounds and methods for modulating cell-adhesion mediated drug resistance |
| 04/24/2003 | US20030078207 Engineered antibiotic peptides and the preparation thereof |
| 04/24/2003 | US20030078204 Produced in prokaryotic cells |
| 04/24/2003 | US20030078202 Receptor derived peptides involved in modulation of response to ligand binding |
| 04/24/2003 | US20030078201 Composition containing peptide and carrier or diluent wherein the peptide has a length of 8 to 50 amino acids, and three preferably consecutive amino acids of peptide are identical to three amino acids of allergenic protein |
| 04/24/2003 | US20030078200 Treating a DSM-III disorder by administering to a mammal a peptide or a peptidomimetic thereof to reduce or eliminate symptoms of the DSM-III disorder |
| 04/24/2003 | US20030078199 Human EphA6 gene and polypeptide |
| 04/24/2003 | US20030078198 For stimulating the proliferation or survival of hematopoietic stem cells exposed to chemotherapeutic agents or irradiation in presence of growth factor |
| 04/24/2003 | US20030078197 For treatment of leukemia; enhancing bone marrow recovery in allogeneic or autologous transplantation and in treatment, radiation, chemically, or chemotherapeutically induced aplasia or myelosuppression |
| 04/24/2003 | US20030078192 Chimeric open reading frames; genetic engineering |
| 04/24/2003 | US20030078191 OrfE is protein of kil gene of bacteriophage; ZipA is protein obtained from Escherichia coli; for inhibition of cellular proliferation |
| 04/24/2003 | US20030077831 Nucleotide sequences for use as efficient gene transfer and cloning tool in genetic engineering |
| 04/24/2003 | US20030077830 Ketogulonigenium endogenous plasmids |
| 04/24/2003 | US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC) |